Pilot study supports tolerability of AC-480 in patients with recurrent malignant glioma June 17, 2011
Phase II ARQ-197 trial assesses safety and efficacy in relapsed/refractory non-CNS germ cell tumors June 17, 2011
Rozrolimupab well tolerated and active in patients with primary immune thrombocytopenia June 16, 2011
Interim first-in-human data support immunological efficacy of EMD-640744 in advanced solid tumors June 16, 2011
RSS